HRS Bibliography

Bibliography Search
Export 8 results:
Filters: First Letter Of Last Name is M and Author is Paola Gilsanz  [Clear All Filters]

Journal Article

Eng CW, Mayeda ER, Gilsanz P, Whitmer RA, Kim AS, M. Glymour M. Temporal Trends in Stroke-Related Memory Change: Results From a US National Cohort 1998-2016. Stroke. 2021;52(5):1702-1711. doi:10.1161/STROKEAHA.120.031063.
Osypuk TL, Ehntholt A, J Moon R, Gilsanz P, M. Glymour M. Neighborhood Differences in Post-Stroke Mortality. Circulaton. Cardiovascular quality and outcomes. 2017;10(2). doi:10.1161/CIRCOUTCOMES.116.002547.
Capistrant BD, Gilsanz P, J Moon R, Kosheleva A, Patton KK, M. Glymour M. Does the association between depressive symptoms and cardiovascular mortality risk vary by race? Evidence from the Health and Retirement Study. Ethn Dis. 2013;23(2):155-60.
http://www.ncbi.nlm.nih.gov/pubmed/23530295?dopt=Abstract
Walter S, Tchetgen Tchetgen EJ, Patton KK, et al. Changes in Depressive Symptoms and Incidence of First Stroke Among Middle-Aged and Older US Adults. J Am Heart Assoc. 2015;4(5). doi:10.1161/JAHA.115.001923.
http://www.ncbi.nlm.nih.gov/pubmed/25971438?dopt=Abstract
Walter S, Tchetgen Tchetgen EJ, Patton KK, et al. Changes in Depressive Symptoms and Incidence of First Stroke Among Middle-Aged and Older US Adults. J Am Heart Assoc. 2015;4(5). doi:10.1161/JAHA.115.001923.
http://www.ncbi.nlm.nih.gov/pubmed/25971438?dopt=Abstract
Mez J, Marden JR, Mukherjee S, et al. Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;8:188-195. doi:10.1016/j.dadm.2017.07.002.
Mez J, Marden JR, Mukherjee S, et al. Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;8:188-195. doi:10.1016/j.dadm.2017.07.002.
Mez J, Marden JR, Mukherjee S, et al. Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;8:188-195. doi:10.1016/j.dadm.2017.07.002.